Expand your Body MRI services
See what’s possible in Body MRI
Whether it’s about imaging patients who cannot hold their breath or about finding the right time point of the arterial phase after contrast injection, FREEZEit1 takes Body MRI to the next level. Check out these cases to experience the convincing results in a clinical and research set-up.
FREEZEit clinical case: Cholangiocarcinoma distinction with TWIST-VIBE
In the case of a 63-year-old male patient whose CT scan showed lesions in the left inferior lobe of the liver, TWIST-VIBE1 helped to see if there is a pancreatic carcinoma or any hepatic metastases in addition to the suspected cholangiocarcinoma. The results led to a sound therapeutic decision by continuing chemotherapy instead of going for surgery and further liver resection.
FREEZEit clinical case: FNH/Adenoma distinction with TWIST-VIBE
In the case of a 54-year-old female patient who showed intrahepatic masses during a sonograph examination, the TWIST-VIBE sequence helped to identify the lesions and distinguish between an Adenoma and FNHs (Focal nodular hyperplasia). Multiple arterial phases made it possible to see the best phase of lesion enhancement, to adequately characterize, and decide for a corresponding treatment.
FREEZEit clinical case: Hepatoblastoma follow-up after post right Hepatectomy with StarVIBE
In the case of a 3-year-old hepatoblastoma patient, StarVIBE1 allowed a free-breathing and contrast-enhanced follow-up examination after partial liver resection.2 With its higher spatial resolution and excellent motion robustness, StarVIBE helped to exclude local recurrence. In addition, the absence of ionizing radiation when using MRI is an advantage for pediatric patients who often undergo further follow-up examinations throughout their lifetime.
The products/features shown on this webpage are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.